-
Signature
-
/s/ Jacquelyn Sumer, Attorney-in-Fact
-
Stock symbol
-
CGEM
-
Transactions as of
-
Nov 25, 2022
-
Transactions value $
-
-$36,000
-
Form type
-
4
-
Date filed
-
11/29/2022, 03:05 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
CGEM |
Common Stock |
Options Exercise |
$17.2K |
+4K |
+7.54% |
$4.30 |
57K |
Nov 25, 2022 |
Direct |
|
transaction |
CGEM |
Common Stock |
Sale |
-$53.2K |
-4K |
-7.01% |
$13.30 |
53K |
Nov 25, 2022 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
CGEM |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-4K |
-1.96% |
$0.00 |
201K |
Nov 25, 2022 |
Common Stock |
4K |
$4.30 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
Chief Development Officer, Biologics Exhibit 24 - Power of Attorney